Cite
HARVARD Citation
Smith, M. et al. (2021). Adverse drug event risk assessment by the virtual addition of COVID‐19 repurposed drugs to Medicare and commercially insured patients' drug regimens: A drug safety simulation study. Clinical and translational science. 14 (5), pp. 1799-1809. [Online].